A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Healthy Volunteers
Interventions
RADIATION

[11C]UCB-J

"* Pharmaceutical form: Sterile solution for intravenous infusion~* Concentration: 20 mCi~* Route of Administration: iv"

DRUG

Brivaracetam

"* Pharmaceutical form: Sterile solution for intravenous infusion~* Concentration: 10 mg/ml~* Route of Administration: iv"

DRUG

Levetiracetam

"* Pharmaceutical form: Sterile solution for intravenous infusion~* Concentration: 100 mg/ml~* Route of Administration: iv"

DRUG

Brivaracetam

"* Pharmaceutical form: Tablets for oral intake~* Concentration: 25 mg~* Route of Administration: oral"

Trial Locations (1)

Unknown

Ep0074 001, New Haven

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

collaborator

Yale University

OTHER

lead

UCB Pharma

INDUSTRY

NCT02602860 - A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers | Biotech Hunter | Biotech Hunter